Avisi is developing a portfolio of ophthalmic treatments based on a novel metamaterial technology. Its flagship product, VisiPlate, is a nanotechnology-enabled implant to treat glaucoma. Glaucoma is the leading cause of irreversible blindness in the world and currently has no cure. To date, Avisi h...
949.294.1086
3401 Grays Ferry Avenue
Philadelphia, 19146
Avisi Technologies’s CEO is Rui Jiang
Avisi Technologies’s HQ is located at 3401 Grays Ferry Avenue, Philadelphia
Avisi Technologies’s phone number is 949.294.1086
Avisi Technologies’s official website is avisitech.com
Avisi Technologies’s revenue is $100k - $1M
Avisi Technologies has 11 - 50 employees
Avisi Technologies is in the industry of: Medical Device